Revefenacin N,N'-dioxide - Request Quote
Revefenacin N,N'-dioxide
| SZ CAT No: | SZ-R043032 |
| CAS No | NA |
| Mol.F. | C35H43N5O6 |
| Mol.Wt. | 629.8 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Revefenacin N,N'-dioxide is chemically 4-(([1,1'-Biphenyl]-2-ylcarbamoyl)oxy)-1-(2-(4-((4-carbamoyl-1-oxidopiperidin-1-yl)methyl)-N-methylbenzamido)ethyl)piperidine 1-oxide. Revefenacin N,N'-dioxide is supplied with detailed characterization data compliant with regulatory guideline. Revefenacin N,N'-dioxide can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Revefenacin.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Revefenacin N,N'-dioxide
Purchase Revefenacin N,N'-dioxide
Revefenacin N,N'-dioxide suppliers
Revefenacin N,N'-dioxide manufacturers
Revefenacin N,N'-dioxide price
Order Revefenacin N,N'-dioxide
Enquire Revefenacin N,N'-dioxide
Revefenacin N,N'-dioxide cost
Revefenacin N,N'-dioxide Supplier
Revefenacin N,N'-dioxide Distributor
Revefenacin N,N'-dioxide for Method Validation
Revefenacin Reference Standard
Revefenacin N,N'-dioxide for ANDA Filing
Revefenacin N,N'-dioxide for Forced Degradation Studies
Revefenacin N,N'-dioxide Identification Standards
Revefenacin N,N'-dioxide for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.